Relationship between topoisomerase II and radiosensitivity in mouse L5178Y lymphoma strains
- 1 January 1989
- journal article
- research article
- Published by Elsevier in Mutation Research/DNA Repair
- Vol. 217 (1), 53-63
- https://doi.org/10.1016/0921-8777(89)90036-0
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK+/−−3.7.2C mouse lymphoma cellsMutation Research/Genetic Toxicology, 1987
- Mutagenicity of m-AMSA and o-AMSA in mammalian cells due to clastogenic mechanism: possible role of topoisomeraseMutagenesis, 1987
- The production of topoisomerase II-mediated DNA cleavage in human leukemia cells predicts their susceptibility to 4′-(9-acridinylamino)methanesulfon-m-anisidide (m-AMSA)Biochemical and Biophysical Research Communications, 1986
- Novobiocin does not inhibit DNA repair in an activve geneCarcinogenesis: Integrative Cancer Research, 1986
- The phosphoform of the regulatory subunit RII of cyclic AMP-dependent protein kinase possesses intrinsic topoisomerase activityCell, 1985
- Topoisomerase II is a structural component of mitotic chromosome scaffolds.The Journal of cell biology, 1985
- A quantitative assay of deoxyribonucleic acid strand breaks and their repair in mammalian cellsAnalytical Biochemistry, 1982
- Novobiocin; an inhibitor of the repair of UV-induced but not X-ray-induced damage in mammalian cellsNucleic Acids Research, 1979
- X-ray induced DNA double strand break production and repair in mammalian cells as measured by neutral filter elutionNucleic Acids Research, 1979
- Mouse Lymphoma Cells with Different RadiosensitivitiesNature, 1961